Zeneca Support Of Nolvadex Risk Claim Includes Lawsuit Against Lilly Evista

Zeneca's expanded support for Nolvadex' breast cancer risk reduction claim includes a lawsuit to prevent Lilly from off-label promotion of its drug Evista for the same indication.